Treace Medical Concepts annual return on equity
2020
2021
2022
2023
2024
2025
Treace Medical Concepts Return on Equity (ROE) Growth & History (TMCI)
Treace Medical Concepts's return on equity was −58.94% for fiscal 2025.
View full Treace Medical Concepts company overviewTreace Medical Concepts annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −58.94% | −14.49 pp |
| 2024 | 2024-12-31 | −44.45% | +5.46 pp |
| 2023 | 2023-12-31 | −49.91% | +5.84 pp |
| 2022 | 2022-12-31 | −55.75% | −11.95 pp |
| 2021 | 2021-12-31 | −43.80% | +142.54 pp |
| 2020 | 2020-12-31 | −186.33% | — |
Treace Medical Concepts quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −21.90% | −4.76 pp |
| Q1 2026 | 2026-03-31 | −21.83% | −7.24 pp |
| Q4 2025 | 2025-12-31 | −10.64% | −10.18 pp |
| Q3 2025 | 2025-09-30 | −17.44% | −3.29 pp |
| Q2 2025 | 2025-06-30 | −17.14% | +0.64 pp |
| Q1 2025 | 2025-03-31 | −14.59% | −0.46 pp |
| Q4 2024 | 2024-12-31 | −0.46% | +4.09 pp |
| Q3 2024 | 2024-09-30 | −14.15% | −1.98 pp |
| Q2 2024 | 2024-06-30 | −17.78% | −9.80 pp |
| Q1 2024 | 2024-03-31 | −14.13% | −1.80 pp |
| Q4 2023 | 2023-12-31 | −4.55% | +2.63 pp |
| Q3 2023 | 2023-09-30 | −12.18% | +5.95 pp |
| Q2 2023 | 2023-06-30 | −7.98% | +13.76 pp |
| Q1 2023 | 2023-03-31 | −12.33% | −2.29 pp |
| Q4 2022 | 2022-12-31 | −7.19% | −0.24 pp |
| Q3 2022 | 2022-09-30 | −18.12% | −11.71 pp |
| Q2 2022 | 2022-06-30 | −21.74% | −11.80 pp |
| Q1 2022 | 2022-03-31 | −10.05% | +5276.91 pp |
| Q4 2021 | 2021-12-31 | −6.95% | −137.35 pp |
| Q3 2021 | 2021-09-30 | −6.41% | — |
| Q2 2021 | 2021-06-30 | −9.94% | — |
| Q1 2021 | 2021-03-31 | −5,286.96% | — |
| Q4 2020 | 2020-12-31 | 130.40% | — |
Treace Medical Concepts return on equity trends
Over the last five fiscal years, Treace Medical Concepts's return on equity increased from −186.33% to −58.94%, a change of +127.40 percentage points. The latest reported quarter, Q2 2026, shows −21.90%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Treace Medical Concepts source filings ↗